Data-Driven vs Consensus Diagnosis of MCI
暂无分享,去创建一个
D. Salmon | M. Bondi | D. Galasko | L. Graves | K. Bangen | L. Delano-Wood | E. Edmonds | K. Thomas | D. Smirnov | Lisa V Graves
[1] M. Bondi,et al. Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders. , 2020, The Journal of infectious diseases.
[2] C. McDonald,et al. Diagnosing cognitive disorders in older adults with epilepsy , 2020, Epilepsia.
[3] M. Bondi,et al. Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia , 2020, Journal of Alzheimer's disease : JAD.
[4] M. Bondi,et al. Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes , 2020, Neurology.
[5] A. Fagan,et al. Concordance of Lumipulse cerebrospinal fluid t‐tau/Aβ42 ratio with amyloid PET status , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[6] Carrie R. McDonald,et al. Early versus late MCI: Improved MCI staging using a neuropsychological approach , 2019, Alzheimer's & Dementia.
[7] L. Schneider,et al. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need , 2018, Alzheimer's & Dementia.
[8] J. Hanfelt,et al. Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center , 2018, Neurobiology of Disease.
[9] C. Jack,et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.
[10] D. Salmon,et al. Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study , 2017, Alzheimer's & dementia.
[11] William T. Hu,et al. Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers , 2017, Alzheimer's Research & Therapy.
[12] J. Weuve,et al. Racial Differences in the Association Between Apolipoprotein E Risk Alleles and Overall and Total Cardiovascular Mortality Over 18 Years , 2017, Journal of the American Geriatrics Society.
[13] R. Petersen,et al. NEUROPSYCHOLOGICAL SUBTYPES OF INCIDENT MILD COGNITIVE IMPAIRMENT IN THE MAYO CLINIC STUDY OF AGING , 2017, Alzheimer's & Dementia.
[14] M. Bondi,et al. Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis , 2017, Journal of the International Neuropsychological Society.
[15] M. Bondi,et al. Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment , 2017, Journal of the International Neuropsychological Society.
[16] Douglas Galasko,et al. NPTX2 and cognitive dysfunction in Alzheimer’s Disease , 2017, eLife.
[17] M. Bondi,et al. Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria , 2016, Neurology.
[18] D. Salmon,et al. "Missed" Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria. , 2016, Journal of Alzheimer's disease : JAD.
[19] M. Bondi,et al. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype. , 2016, Journal of Alzheimer's disease : JAD.
[20] Paul E. Gilbert,et al. Elevated rates of mild cognitive impairment in HIV disease , 2015, Journal of NeuroVirology.
[21] M. Bondi,et al. Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors , 2015, Alzheimer's & Dementia.
[22] D. Salmon,et al. Subjective Cognitive Complaints Contribute to Misdiagnosis of Mild Cognitive Impairment Nih Public Access , 2022 .
[23] Wiesje M van der Flier,et al. Progression to dementia in memory clinic patients without dementia , 2013, Neurology.
[24] D. Salmon,et al. Are Empirically-Derived Subtypes of Mild Cognitive Impairment Consistent with Conventional Subtypes? , 2013, Journal of the International Neuropsychological Society.
[25] M. Summers,et al. Absence of a relationship between subjective memory complaint and objective memory impairment in mild cognitive impairment (MCI): is it time to abandon subjective memory complaint as an MCI diagnostic criterion? , 2012, International Psychogeriatrics.
[26] Leslie M. Shaw,et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative , 2012, Alzheimer's & Dementia.
[27] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[28] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[29] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[30] W. Jagust,et al. Validation of consensus panel diagnosis in dementia. , 2010, Archives of neurology.
[31] Tania Giovannetti,et al. The heterogeneity of mild cognitive impairment: A neuropsychological analysis , 2009, Journal of the International Neuropsychological Society.
[32] M. Bondi,et al. Heterogeneity in mild cognitive impairment: Differences in neuropsychological profile and associated white matter lesion pathology , 2009, Journal of the International Neuropsychological Society.
[33] Nathaniel Mercaldo,et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.
[34] A. Mitchell,et al. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. , 2009, Journal of psychiatric research.
[35] J. Schneider,et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.
[36] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[37] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[38] R. Terry,et al. Position Paper on Diagnostic Criteria for Alzheimer Disease , 1997, Neurobiology of Aging.
[39] John Q. Trojanowski,et al. Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.
[40] K. Jellinger,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.
[41] L A Hansen,et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.
[42] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[43] M Haupt,et al. [Clinical diagnosis of Alzheimer's disease]. , 1988, Deutsche medizinische Wochenschrift.